$200.00
FOXO4-DRI is an experimental senolytic peptide designed to eliminate senescent cells by disrupting the FOXO4-p53 interaction. By targeting dysfunctional cells that drive chronic inflammation and tissue aging, FOXO4-DRI represents a promising frontier in longevity and regenerative medicine research. A central process contributing to the phenotype of aging is cellular senescence. The FOXO4-p53 axis has been identified as pivotal in maintaining the viability of senescent cells, and FOXO4-DRI was developed to selectively target this axis.
Become a Member and save 20% on every order.
Become a MemberEach peptide is manufactured to exact specifications using controlled processes—no fillers, no compromises.
Every order is traceable by batch, giving you clear documentation, consistency, and confidence in every purchase.
Independent laboratory testing is provided for every peptide, with full results available on each product page.
